STXS: Summary for Stereotaxis, Inc. - Yahoo! Canada Finance

MORE ON STXS

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Stereotaxis, Inc. (NGM:STXS) Delayed quote data

Last Trade:	4.25 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	4.25
Open:	N/A
Bid:	3.50 x 500
Ask:	1,999.00 x 300
1y Target Est:	6.30

Day's Range:	N/A - N/A
52wk Range:	2.78 - 5.19
Volume:	0
Avg Vol (3m):	225,116
Market Cap:	213.60M
P/E (ttm):	N/A
EPS (ttm):	-0.70
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add STXS to Portfolio

Download Data

HEADLINES

•	Stereotaxis Announces Fourth Quarter 2009 Earnings Release Date and Conference Call
	PRNewswire (Tue 6:00am)

•	Stereotaxis installs 1st system in Taiwan
	at bizjournals.com (Mon, Feb 8)

•	Stereotaxis Installs First System in Taiwan
	PRNewswire (Mon, Feb 8)

•	Stereotaxis equipment on âTodayâ show
	at bizjournals.com (Mon, Feb 1)

•	Stereotaxis System Procedure Featured on NBC's The TODAY Show
	PRNewswire (Mon, Feb 1)

•	Coverage initiated on Stereotaxis by Oppenheimer
	Briefing.com (Fri, Jan 15)

•	Stereotaxis device gets FDA OK
	at bizjournals.com (Tue, Jan 12)

•	Cirrus Logic, Zareba Systems: Early Volume Plays
	at TheStreet.com (Tue, Jan 12)

•	Early-Market Movers: Cirrus Logic, Electronic Arts
	at Fox Business (Tue, Jan 12)

•	Stereotaxis says FDA clears magnetic catheter
	AP (Tue, Jan 12)

More Headlines for STXS...

ANALYST

EPS Est (next year) (Dec-09) :	-0.62
EPS Est (in 2 years) (Dec-10) :	-0.36
Avg Rec (current)*:	1.5
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Stereotaxis, Inc. designs, manufactures, and markets cardiology instrument control system for use in hospitals interventional surgical suite or interventional lab to treat arrhythmias and coronary artery disease in the United States, Canada,...

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

Stereotaxis Inc. (STXS)